Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Virogin Biotech | 2021 | Series D | Undisclosed | Vancouver |
| Airgram | 2022 | Series A | Undisclosed | Wilmington |
| RootPath | 2025 | Venture - Series Unknown | Undisclosed | Cambridge |
| ReviR Therapeutics | 2026 | Corporate Round | Undisclosed | Brisbane |
| Deep Intelligent Pharma | 2026 | Series Unknown | $40.0M | Singapore |
| Zelostech | 2026 | Corporate Round | Undisclosed | Singapore |
| AusperBio | 2025 | Series B | $63.0M | Foster City |
| Spear Bio | 2024 | Series A | $45.0M | Weston |
| BrainCo | 2026 | Venture - Series Unknown | $286.4M | Somerville |
| Weiguang Dianliang | 2026 | Seed | $14.4M | Shenzhen |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Virogin Biotech | Series D | Undisclosed | Vancouver, Canada |
| 2 | Airgram | Series A | Undisclosed | Wilmington, United States |
| 3 | RootPath | Venture - Series Unknown | Undisclosed | Cambridge, United States |
| 4 | ReviR Therapeutics | Corporate Round | Undisclosed | Brisbane, United States |
| 5 | Deep Intelligent Pharma | Series Unknown | $40.0M | Singapore, Singapore |
| 6 | Zelostech | Corporate Round | Undisclosed | Singapore, Singapore |
| 7 | AusperBio | Series B | $63.0M | Foster City, United States |
| 8 | Spear Bio | Series A | $45.0M | Weston, United States |
| 9 | BrainCo | Venture - Series Unknown | $286.4M | Somerville, United States |
| 10 | Weiguang Dianliang | Seed | $14.4M | Shenzhen, China |
Virogin Biotech is an antineoplastic drug developer.
An Airgram is a real-time transcription with speaker identification and high-definition video recording.
RootPath is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Deep Intelligent Pharma is a Singapore based AI Clinical Trial Company
Zelostech is the world’s largest RoboVan enterprise and a global leader in autonomous driving technology
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.
BrainCo develops brain-computer interface technologies for wellness and education applications.
Weiguang Dianliang is an innovative company specializing in AI-agent intelligent hardware.
Robot Era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products.
Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Huamei Haolian specializes in providing telemedicine and medical tourism services.
Mianbi Smart enables large-scale model acceleration and application execution using artificial intelligence.
Jinjing Keji manufactures cathode fluorescence system instruments.
HjMicro develops higher efficiency and easier deployment server processor (CPU) chips based on the ARM architecture.
Zelos is an AI-driven startup is the way in autonomous driving technology.
Edrive Space develops aerospace propulsion systems for the aerospace industry.
Daxiang Biotech develops and produces human organoid chips.
Lingxin Qiaoshou focuses on the research and development and production of embodied intelligent platforms
UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.
iSpace designs and develops commercial space shuttle.
Neolix is a technology company that designs, manufactures, and operates low-cost autonomous delivery vehicles.
Zhongke Qingneng is a green-tech company that specializes in the development and manufacturing of hydrogen liquefaction equipment.
Realm of Illumination is an AI smarter hardware company that specializes in R&D for AI smart terminal equipment.
CDH Investments has invested in 137 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
CDH Investments's top investment sectors include Biotechnology, Artificial Intelligence (AI), Health Care, Manufacturing, Automotive. The firm invests across 37 different industry categories.
Among tracked funding rounds, iSpace China received $727.6M in a Series D round. CDH Investments's total known invested capital is $6.2B.
CDH Investments's average investment size is $73.5M across its portfolio of 137 companies.
Recent CDH Investments portfolio additions include Virogin Biotech, Airgram, RootPath, ReviR Therapeutics, Deep Intelligent Pharma. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors